Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;52(4):486-490.
doi: 10.1007/s11055-022-01265-9. Epub 2022 Jul 20.

Vaccination and Multiple Sclerosis - Current Situation

A N Boyko  1   2 , S A Sivertseva  3 , D S Chemakina  4 , N N Spirin  5 , O V Bykova  6 , M E Guseva  1
Affiliations

Vaccination and Multiple Sclerosis - Current Situation

A N Boyko et al. Neurosci Behav Physiol. 2022.

Abstract

Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations.

Keywords: COVID-19; autoimmune diseases; multiple sclerosis; vaccination.

PubMed Disclaimer

References

    1. S. Pazmino, A. Boonen, V. Stouten, et al., “Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial,” Ann. Rheum. Dis., 79, No. 5, 556–665 (2020), https://doi.org/10.1136/annrheumdis-2019-216874. - PubMed
    1. S. Ghabri, A. Binard, Y.-M. Pers, et al., “Economic evaluation of sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis and inadequate response or intolerance to methotrexate in France,” Value Health, 23, No. 4, 461–470 (2020), https://doi.org/10.1016/j.jval.2019.12.003. - PubMed
    1. P. Katz, G. J. Wan, and P. Daly, et al., “Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus,” Qual. Life Res., 29, No. 12, 3251–3261 (2020), https://doi.org/10.1007/s11136-020-02572-9. - PubMed
    1. Ø. Hovde, “Epidemiology and clinical course of Crohn’s disease: Results from observational studies,” World J. Gastroenterol., 18, No. 15, 1723 (2012), https://doi.org/10.3748/wjg.v18.i15.1723. - PMC - PubMed
    1. L. Wang, F.-S. Wang, and M. E. Gershwin, “Human autoimmune diseases: a comprehensive update,” J. Intern. Med., 278, No. 4, 369–395 (2015), https://doi.wiley.com/https://doi.org/10.1111/joim.12395. - PubMed

LinkOut - more resources